Skip to main content

Displaying 2281 - 2300 of 2528

Public Statement

What Are We Learning from the Microsoft Case?

Date
Good morning. I am glad to be here today to offer opening remarks to today's discussion about what we are learning from the Microsoft case and other government antitrust cases against those in high...

Announced Actions for September 16, 1999

Date
Approval of Omnibus Compulsory Process Resolution: To ensure that its staff has the tools necessary to combat fraud and deception on the Internet, the Federal Trade Commission today announced that it...
Public Statement

Antitrust in a Global High-Tech Economy

Date
There is nothing constant except change. Not surprisingly then, my topic today is the challenges that you and I face in addressing competition problems in this fast-changing global, high tech economy...
Report

21st Report (FY 1998)

Date
Federal Trade Commission Bureau of Competition Department of Justice Antitrust Division Annual Report to Congress Fiscal Year 1998 Pursuant to Subsection (j) of Section 7A of the Clayton Act Hart...
Public Statement

Licensing and Antitrust: Common Goals and Uncommon Problems

Date
I am delighted to be here today to speak about licensing and antitrust. When I speak on this subject to gatherings of intellectual property practitioners, I sometimes feel as if I am attempting to...
Report

20th Report (FY 1997)

Date
Pursuant to Subsection (j) of Section 7A of the Clayton Act Hart-Scott-Rodino Antitrust Improvements Act of 1976 (Twentieth Report) Federal Trade Commission Bureau of Competition Department of Justice...

CVS Corporation, and Revco D.S., Inc.

CVS agreed to settle allegations that its acquisition of Revco would substantially reduce competition for the retail sale of pharmacy services to health insurance companies and other third-party payers in Virginia and in the Binghamton, New York metropolitan area. The consent order requires the divestiture of 114 Revco stores in Virginia and 6 pharmacy counters in Binghamton.

In March, 1998, CVS Corporation agreed to pay a $600,000 civil penalty to settle Federal Trade Commission charges that the company violated a 1997 consent order and asset maintenance agreement it signed with the agency to settle charges stemming from CVS's 1997 acquisition of Revco D.S., Inc.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
971 0060
Docket Number
C-3762